Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.

CP: Cancer CP: Molecular biology Cushing’s disease DNA methylation bortezomib preclinical testing proteasome single-cell RNA-seq sporadic pituitary adenoma

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
23 08 2022
Historique:
received: 14 06 2021
revised: 03 06 2022
accepted: 26 07 2022
entrez: 24 8 2022
pubmed: 25 8 2022
medline: 27 8 2022
Statut: ppublish

Résumé

Sporadic pituitary adenomas occur in over 10% of the population. Hormone-secreting adenomas, including those causing Cushing's disease (CD), cause severe morbidity and early mortality. Mechanistic studies of CD are hindered by a lack of in vitro models and control normal human pituitary glands. Here, we surgically annotate adenomas and adjacent normal glands in 25 of 34 patients. Using single-cell RNA sequencing (RNA-seq) analysis of 27594 cells, we identify CD adenoma transcriptomic signatures compared with adjacent normal cells, with validation by bulk RNA-seq, DNA methylation, qRT-PCR, and immunohistochemistry. CD adenoma cells include a subpopulation of proliferating, terminally differentiated corticotrophs. In CD adenomas, we find recurrent promoter hypomethylation and transcriptional upregulation of PMAIP1 (encoding pro-apoptotic BH3-only bcl-2 protein noxa) but paradoxical noxa downregulation. Using primary CD adenoma cell cultures and a corticotroph-enriched mouse cell line, we find that selective proteasomal inhibition with bortezomib stabilizes noxa and induces apoptosis, indicating its utility as an anti-tumor agent.

Identifiants

pubmed: 36001971
pii: S2211-1247(22)01040-3
doi: 10.1016/j.celrep.2022.111223
pmc: PMC9527711
mid: NIHMS1833590
pii:
doi:

Substances chimiques

Adrenocorticotropic Hormone 9002-60-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

111223

Subventions

Organisme : Intramural NIH HHS
ID : ZIA NS003150
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Oncogene. 2014 Apr 24;33(17):2191-203
pubmed: 23686310
Science. 2020 Oct 23;370(6515):463-467
pubmed: 33093109
Nat Genet. 2015 Jan;47(1):31-8
pubmed: 25485838
Exp Cell Res. 2005 Aug 1;308(1):166-76
pubmed: 15916758
Histochemistry. 1994 Oct;102(4):287-96
pubmed: 7843991
Diagn Histopathol. 1981 Oct-Dec;4(4):335-41
pubmed: 6279372
Ultrastruct Pathol. 1999 May-Jun;23(3):141-8
pubmed: 10445280
Microsc Res Tech. 1997 Oct 15;39(2):138-49
pubmed: 9361265
Am J Med. 1952 Nov;13(5):597-614
pubmed: 12996538
Elife. 2021 Jan 05;10:
pubmed: 33399538
J Endocrinol Invest. 1999 Jan;22(1):12-7
pubmed: 10090131
Endocrinology. 2011 Oct;152(10):3603-13
pubmed: 21810943
J Clin Endocrinol Metab. 1994 Jul;79(1):253-7
pubmed: 8027238
Mol Cell Endocrinol. 2018 Jul 15;470:105-114
pubmed: 28986303
J Clin Endocrinol Metab. 1991 Dec;73(6):1302-8
pubmed: 1720126
Oncotarget. 2017 Apr 25;8(17):29282-29299
pubmed: 28418929
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2375-2384
pubmed: 30715394
Clin Med Res. 2006 Jun;4(2):130-7
pubmed: 16809406
J Clin Invest. 1990 Jul;86(1):336-40
pubmed: 1973174
Nucleic Acids Res. 2014;42(16):10433-47
pubmed: 25147211
Endocrinology. 2005 Sep;146(9):3985-98
pubmed: 15932930
J Clin Endocrinol Metab. 2008 May;93(5):1526-40
pubmed: 18334580
Cancer. 2004 Aug 1;101(3):613-9
pubmed: 15274075
Cell. 2001 Mar 23;104(6):849-59
pubmed: 11290323
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8674-9
pubmed: 11447259
Eur J Endocrinol. 2014 Oct;171(4):519-26
pubmed: 25084775
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2179-2187
pubmed: 28323961
J Clin Endocrinol Metab. 1994 Feb;78(2):418-22
pubmed: 8106630
Acta Endocrinol (Copenh). 1992 Jul;127(1):13-7
pubmed: 1519417
World Neurosurg. 2017 Jan;97:2-7
pubmed: 27671881
Nucleic Acids Res. 2018 Nov 30;46(21):11370-11380
pubmed: 30357357
Cell Death Dis. 2014 Jan 23;5:e1013
pubmed: 24457957
Nat Commun. 2018 Aug 9;9(1):3171
pubmed: 30093687
Mol Endocrinol. 1997 Apr;11(4):433-41
pubmed: 9092795
J Histochem Cytochem. 1953 Mar;1(2):93-113
pubmed: 13035080
Cell Rep. 2018 Feb 20;22(8):2216-2225
pubmed: 29466745
Cell Stem Cell. 2014 Jan 2;14(1):68-80
pubmed: 24239285
Science. 2000 May 12;288(5468):1053-8
pubmed: 10807576
Endocrinology. 2018 Dec 1;159(12):3910-3924
pubmed: 30335147
Clin Endocrinol (Oxf). 2006 Oct;65(4):536-43
pubmed: 16984249
Cell. 2016 Apr 21;165(3):535-50
pubmed: 27104977
J Clin Invest. 2011 Dec;121(12):4712-21
pubmed: 22105169
Clin Cancer Res. 2018 Sep 1;24(17):4126-4136
pubmed: 30084836
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
J Neurosurg. 2017 Feb;126(2):404-417
pubmed: 27104844
J Endocrinol. 2004 Nov;183(2):385-94
pubmed: 15531726
Cell Res. 2015 Mar;25(3):306-17
pubmed: 25675982
Brain Res. 1980 Jun 9;191(2):523-31
pubmed: 6991054
J Endocrinol. 2017 Sep;234(3):R135-R158
pubmed: 28615294
Acta Neurol Scand. 1995 Aug;92(2):157-60
pubmed: 7484065
Proc Soc Exp Biol Med. 1953 Oct;84(1):253-4
pubmed: 13121002
Pituitary. 2016 Dec;19(6):612-624
pubmed: 27678103
Am J Anat. 1975 Jun;143(2):137-61
pubmed: 167574
Eur J Endocrinol. 1994 May;130(5):530-9
pubmed: 8180683
Stem Cells. 2009 May;27(5):1182-95
pubmed: 19418455
Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6332-7
pubmed: 18436641
J Clin Endocrinol Metab. 1990 Dec;71(6):1427-33
pubmed: 1977759
J Clin Endocrinol Metab. 1999 Feb;84(2):761-7
pubmed: 10022450
J Neurosurg. 1998 Jun;88(6):1111-5
pubmed: 9609310
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
Pituitary. 2013 Jun;16(2):139-45
pubmed: 22466318
Nat Commun. 2020 Oct 19;11(1):5275
pubmed: 33077725
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
J Clin Endocrinol Metab. 1998 Apr;83(4):1163-7
pubmed: 9543134
Cancer Cell. 2020 Jan 13;37(1):123-134.e5
pubmed: 31883967
Mol Syst Biol. 2011 Jul 19;7:514
pubmed: 21772262
J Exp Med. 2008 May 12;205(5):1109-20
pubmed: 18411339
J Clin Pathol. 1996 Oct;49(10):795-7
pubmed: 8943742
J Biol Chem. 2014 Jun 20;289(25):17802-11
pubmed: 24811167
J Clin Endocrinol Metab. 1993 Nov;77(5):1308-12
pubmed: 8077325
J Clin Endocrinol Metab. 2008 Oct;93(10):4119-25
pubmed: 18628527
Front Endocrinol (Lausanne). 2019 Sep 18;10:623
pubmed: 31620083
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2825-2835
pubmed: 28505327
J Clin Endocrinol Metab. 1994 Jan;78(1):131-7
pubmed: 7507118
J Cell Mol Med. 2018 Dec;22(12):6213-6227
pubmed: 30255595
Cell Stem Cell. 2013 Oct 3;13(4):433-45
pubmed: 24094324
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Cell Rep. 2013 Mar 28;3(3):881-91
pubmed: 23499448
J Clin Endocrinol Metab. 2015 Aug;100(8):3165-71
pubmed: 26147609
Endocrinology. 2000 Dec;141(12):4457-65
pubmed: 11108255
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19488-93
pubmed: 18042711
Expert Opin Ther Targets. 2017 Aug;21(8):767-779
pubmed: 28670929
J Clin Endocrinol Metab. 2009 Aug;94(8):2930-7
pubmed: 19509103
Clin Endocrinol (Oxf). 1994 Nov;41(5):649-54
pubmed: 7828354
Mol Endocrinol. 2012 Mar;26(3):447-57
pubmed: 22301782
Horm Metab Res. 2011 May;43(5):325-30
pubmed: 21351040
Protein Cell. 2020 Aug;11(8):565-583
pubmed: 32193873
Mol Endocrinol. 2005 May;19(5):1383-91
pubmed: 15677710
Clin Cancer Res. 2017 Apr 1;23(7):1841-1851
pubmed: 27707790

Auteurs

David T Asuzu (DT)

Neurosurgery Unit for Pituitary and Inheritable Diseases, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Room 3D20, Bethesda, MD 20892, USA; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA; Department of Neurosurgery, University of Virginia, Charlottesville, VA, USA.

Reinier Alvarez (R)

Neurosurgery Unit for Pituitary and Inheritable Diseases, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Room 3D20, Bethesda, MD 20892, USA; Florida International University Herbert Wertheim College of Medicine, Miami, FL, USA.

Patrick A Fletcher (PA)

Laboratory of Biological Modeling, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, MD, USA.

Debjani Mandal (D)

Neurosurgery Unit for Pituitary and Inheritable Diseases, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Room 3D20, Bethesda, MD 20892, USA.

Kory Johnson (K)

DIR Bioinformatics Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.

Weiwei Wu (W)

Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.

Abdel Elkahloun (A)

Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.

Paul Clavijo (P)

Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, Bethesda, MD, USA.

Clint Allen (C)

Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, Bethesda, MD, USA.

Dragan Maric (D)

Flow and Imaging Cytometry Core Facility, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.

Abhik Ray-Chaudhury (A)

Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA; Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.

Sharika Rajan (S)

Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.

Zied Abdullaev (Z)

Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.

Diana Nwokoye (D)

Neurosurgery Unit for Pituitary and Inheritable Diseases, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Room 3D20, Bethesda, MD 20892, USA.

Kenneth Aldape (K)

Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.

Lynnette K Nieman (LK)

Section on Translational Endocrinology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.

Constantine Stratakis (C)

Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.

Stanko S Stojilkovic (SS)

Section on Cellular Signaling, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.

Prashant Chittiboina (P)

Neurosurgery Unit for Pituitary and Inheritable Diseases, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Room 3D20, Bethesda, MD 20892, USA; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA. Electronic address: prashant.chittiboina@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH